Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation

查看全文 作　　者：Hugo;F;Fernandez;Hai;T;Tran;Federico;Albrecht;Shari;Lennon;Humberto;Caldera;Mark;S;Goodman 出　　处：《Biology of Blood and Marrow Transplantation》索引2002年第9期,共0页